Precise Biometrics AB (publ)
PRBCF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $87 | $75 | $91 | $83 |
| % Growth | 15.7% | -17.5% | 9.2% | – |
| Cost of Goods Sold | $24 | $27 | $26 | $20 |
| Gross Profit | $63 | $48 | $65 | $64 |
| % Margin | 72.6% | 63.7% | 71.5% | 76.3% |
| R&D Expenses | $27 | $32 | $35 | $28 |
| G&A Expenses | $14 | $14 | $18 | $18 |
| SG&A Expenses | $47 | $42 | $52 | $50 |
| Sales & Mktg Exp. | $33 | $27 | $35 | $32 |
| Other Operating Expenses | -$1 | $1 | -$2 | -$0 |
| Operating Expenses | $72 | $74 | $85 | $78 |
| Operating Income | -$9 | -$26 | -$20 | -$14 |
| % Margin | -10.8% | -35.2% | -22% | -16.9% |
| Other Income/Exp. Net | $1 | -$0 | -$3 | $1 |
| Pre-Tax Income | -$9 | -$27 | -$23 | -$13 |
| Tax Expense | -$0 | -$0 | -$1 | $0 |
| Net Income | -$8 | -$26 | -$22 | -$13 |
| % Margin | -9.7% | -35.2% | -24.4% | -16.1% |
| EPS | -0.11 | -0.4 | -0.47 | -0.32 |
| % Growth | 72.5% | 14.9% | -46.9% | – |
| EPS Diluted | -0.11 | -0.4 | -0.47 | -0.32 |
| Weighted Avg Shares Out | 78 | 66 | 47 | 42 |
| Weighted Avg Shares Out Dil | 78 | 66 | 47 | 42 |
| Supplemental Information | – | – | – | – |
| Interest Income | $1 | $1 | $0 | $0 |
| Interest Expense | $0 | $1 | $3 | $0 |
| Depreciation & Amortization | $4 | $25 | $21 | $4 |
| EBITDA | -$6 | -$2 | -$1 | -$9 |
| % Margin | -6.6% | -2.3% | -1.1% | -11.2% |